Jorge Luis Martinez Torrecuadrada

Title: Jorge Luis Martinez Torrecuadrada: Innovator in Antibody Research

Introduction

Jorge Luis Martinez Torrecuadrada is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

One of his latest patents is the "Anti-ephrin-B2 antibody and compositions comprising it." This invention relates to a novel antibody against ephrin B2, which is crucial for detecting the protein and serves as a medicament for inhibiting angiogenesis and lymphangiogenesis in the treatment of diseases such as cancer. Another significant patent is the "Icosahedral superstructure of VP2 of infectious bursitis virus (IBDV) and the application thereof." This patent describes IBDV VP2 icosahedral superstructures, which consist of 12 empty VP2 dodecahedral capsids. These structures, measuring approximately 60–68 nm in diameter and containing 720 IBDV VP2 subunits, can be utilized for vaccinal and diagnostic purposes.

Career Highlights

Throughout his career, Jorge has worked with notable organizations, including the Fundación Centro Nacional de Investigaciones Oncológicas (CNIO) and Inmunología y Genética Aplicada, S.A. His research has been instrumental in advancing the understanding of antibody applications in medical science.

Collaborations

Jorge has collaborated with esteemed colleagues such as Maria Angeles Abengozar Infantes and Jose Ruiz Caston. Their joint efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Jorge Luis Martinez Torrecuadrada is a distinguished inventor whose work in antibody research has the potential to impact medical treatments significantly. His innovative patents and collaborations highlight his commitment to advancing biotechnology.